Cargando…

Raloxifene Suppresses Tumor Growth and Metastasis in an Orthotopic Model of Castration-Resistant Prostate Cancer

Androgen receptor (AR)-castrate-resistant prostate cancer (CRPC) is an aggressive form of prostate cancer that does not have clinically approved targeted treatment options. To this end, the cytotoxic potential of raloxifene and the synthetic curcumin derivative 2,6-bis (pyridin-4-ylmethylene)-cycloh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Palmer, Hannah, Nimick, Mhairi, Mazumder, Aloran, Taurin, Sebastien, Rana, Zohaib, Rosengren, Rhonda J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9033055/ https://www.ncbi.nlm.nih.gov/pubmed/35453603 http://dx.doi.org/10.3390/biomedicines10040853

Ejemplares similares

A Novel Role for Raloxifene Nanomicelles in Management of Castrate Resistant Prostate Cancer
por: Taurin, Sebastien, et al.
Publicado: (2014)

Styrene maleic acid-encapsulated RL71 micelles suppress tumor growth in a murine xenograft model of triple negative breast cancer
por: Martey, Orleans, et al.
Publicado: (2017)

A combination of sorafenib and nilotinib reduces the growth of castrate-resistant prostate cancer
por: Archibald, Monica, et al.
Publicado: (2016)

Anti-Proliferative, Anti-Angiogenic and Safety Profiles of Novel HDAC Inhibitors for the Treatment of Metastatic Castration-Resistant Prostate Cancer
por: Rana, Zohaib, et al.
Publicado: (2021)

In Vitro Hepatic Assessment of Cineole and Its Derivatives in Common Brushtail Possums (Trichosurus vulpecula) and Rodents
por: Chand, Ravneel R., et al.
Publicado: (2021)

Investigating the Contribution of Major Drug-Metabolising Enzymes to Possum-Specific Fertility Control
por: Chand, Ravneel R., et al.
Publicado: (2023)

Understanding Failure and Improving Treatment Using HDAC Inhibitors for Prostate Cancer
por: Rana, Zohaib, et al.
Publicado: (2020)

Styrene maleic acid encapsulated raloxifene micelles for management of inflammatory bowel disease
por: Greish, Khaled, et al.
Publicado: (2017)

Exploring the Mechanism and Suggesting Combination Therapies for HDAC Inhibitors in Androgen Receptor-Null Prostate Cancer Using Multivariate Statistical Analysis and Data Mining Techniques
por: Rana, Zohaib, et al.
Publicado: (2022)

Does the mouse tail vein injection method provide a good model of lung cancer?
por: Shrestha, Nensi, et al.
Publicado: (2019)

Cytostatic Action of Novel Histone Deacetylase Inhibitors in Androgen Receptor-Null Prostate Cancer Cells
por: Rana, Zohaib, et al.
Publicado: (2021)

Mechanisms of suppression of cell growth by dual inhibition of ALK and MEK in ALK-positive non-small cell lung cancer
por: Shrestha, N., et al.
Publicado: (2019)

Terphenyllin Suppresses Orthotopic Pancreatic Tumor Growth and Prevents Metastasis in Mice
por: Zhang, Jia, et al.
Publicado: (2020)

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
por: Pavese, Janet, et al.
Publicado: (2013)

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
por: Anker, Jonathan F., et al.
Publicado: (2018)

Raloxifene in Hemodialysis Patients
por: Keller, Frieder
Publicado: (2012)

Oxidative Stress and Raloxifene
por: Akgol, Gurkan, et al.
Publicado: (2012)

Estradiol suppresses tissue androgens and prostate cancer growth in castration resistant prostate cancer
por: Montgomery, Bruce, et al.
Publicado: (2010)

Restoration of PPP2CA expression reverses epithelial-to-mesenchymal transition and suppresses prostate tumour growth and metastasis in an orthotopic mouse model
por: Bhardwaj, A, et al.
Publicado: (2014)

Generation of a syngeneic orthotopic transplant model of prostate cancer metastasis
por: Ellis, Leigh, et al.
Publicado: (2014)

Visceral Metastasis Predicts Response to New Hormonal Agents in Metastatic Castration-Sensitive Prostate Cancer
por: Yekedüz, Emre, et al.
Publicado: (2023)

Safety of Raloxifene in Hemodialysis Patients
por: Jacobsen, Didy
Publicado: (2012)

Co‐consuming green tea with raloxifene decreases raloxifene systemic exposure in healthy adult participants
por: Clarke, John D., et al.
Publicado: (2023)

Raloxifene inhibits tumor growth and lymph node metastasis in a xenograft model of metastatic mammary cancer
por: Shibata, Masa-Aki, et al.
Publicado: (2010)

Metastasis-Directed Radiotherapy for Oligometastatic Castration-Resistant Prostate Cancer
por: Katano, Atsuto, et al.
Publicado: (2021)

Aminomethylphosphonic acid inhibits growth and metastasis of human prostate cancer in an orthotopic xenograft mouse model
por: Parajuli, Keshab Raj, et al.
Publicado: (2016)

Deguelin Suppresses Pancreatic Tumor Growth and Metastasis by Inhibiting Epithelial to Mesenchymal Transition in an Orthotopic Model()
por: Boreddy, Srinivas Reddy, et al.
Publicado: (2012)

Alendronate decreases orthotopic PC-3 prostate tumor growth and metastasis to prostate-draining lymph nodes in nude mice
por: Tuomela, Johanna M, et al.
Publicado: (2008)

Regulated Expression of CCL21 in the Prostate Tumor Microenvironment Inhibits Tumor Growth and Metastasis in an Orthotopic Model of Prostate Cancer
por: Yousefieh, Nazita, et al.
Publicado: (2009)

Growth-suppressive activity of raloxifene on liver cancer cells by targeting IL-6/GP130 signaling
por: Wang, Yina, et al.
Publicado: (2017)

Hemostatic Effects of Raloxifene in Ovariectomized Rats
por: Alva-Chavarría, Denys, et al.
Publicado: (2023)

Three cases of brain metastasis from castration‐resistant prostate cancer
por: Shida, Yohei, et al.
Publicado: (2019)

ALK and IGF-1R as independent targets in crizotinib resistant lung cancer
por: Wilson, Christabel, et al.
Publicado: (2017)

Styrene maleic acid-encapsulated paclitaxel micelles: antitumor activity and toxicity studies following oral administration in a murine orthotopic colon cancer model
por: Parayath, Neha N, et al.
Publicado: (2016)

Menin inhibition suppresses castration-resistant prostate cancer and enhances chemosensitivity
por: Cherif, Chaïma, et al.
Publicado: (2021)

Castration for Prostatic Hypertrophy
Publicado: (1899)

Denosumab: Delay of bone metastasis in men with nonmetastatic castrate-resistant prostate cancer
por: Manger, Jules P., et al.
Publicado: (2012)

Unusual presentation of castrate-resistant prostate cancer with urethral and inguinal nodal metastasis
por: Jindal, Tarun, et al.
Publicado: (2021)

Castration-resistant prostate cancer with metastasis to external auditory canal – Case report
por: Akagi, Naoki, et al.
Publicado: (2022)

Raloxifene for older women: a review of the literature
por: Hansdóttir, Helga
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_v0r6g7f444en0sd74ck5l8quqn